Chung-Che Wang

Title: Innovations by Chung-Che Wang in Analyte Prediction

Introduction

Chung-Che Wang is an accomplished inventor based in Palo Alto, CA. He has made significant contributions to the field of analyte monitoring through his innovative patent. His work focuses on improving the accuracy of analyte level predictions, which is crucial for users relying on continuous health monitoring.

Latest Patents

Chung-Che Wang holds a patent titled "Predicting analyte levels based on intermittent sensor data." This patent discloses techniques for predicting analyte levels based on intermittent sensor data. The process involves acquiring first sensor data from an analyte sensor worn by a user. This data reflects the user's analyte levels and is collected over a specified time period. When it is determined that data acquisition from the sensor has ceased, the first sensor data is classified as intermittent analyte data. This intermittent data is then utilized to generate predicted analyte level data for the user during a subsequent time period, ensuring that the predictions are reflective of the intermittent data collected.

Career Highlights

Chung-Che Wang is associated with Abbott Diabetes Care Inc., a company known for its advancements in diabetes management technologies. His work at Abbott has been pivotal in enhancing the capabilities of analyte sensors, thereby improving patient care and monitoring.

Collaborations

Chung-Che Wang has collaborated with notable colleagues, including Shridhara Alva Karinka and Vivek S Rao. These collaborations have contributed to the development of innovative solutions in the field of health monitoring.

Conclusion

Chung-Che Wang's contributions to the field of analyte prediction through his patent demonstrate his commitment to advancing health technology. His work not only enhances the accuracy of health monitoring but also plays a vital role in improving the quality of life for users.